Advanced Search

Oncology & Hematology Coding Alert

HCPCS Update:

Not Coding For Daratumumab Yet? Update Your HCPCS Code List

Published on Thu Dec 08, 2016

You can only claim for combination therapy with daratumumab. Breaking news: daratumumab has received U.S. Food and Drug Administration (FDA) approval. On Nov 21, 2016, the FDA approved daratumumab for combination therapy in multiple myeloma. This means you need to have your codes ready. More info: For more on FDA approval of daratumumab, you can go to URL: www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm530249.htm [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All